Introduction People living with advanced respiratory diseases do not receive the supportive and palliative care that they need to have the best possible quality of life [1 – 4]. Globally, many millions of people live with advanced respiratory diseases [5], including chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Introduction People living with advanced respiratory diseases do not receive the supportive and palliative care that they need to have the best possible quality of life [1 – 4]. Globally, many millions of people live with advanced respiratory diseases [5], including chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Given that the global distribution of COPD continues to rise exponentially, addressing respiratory health priorities has become crucial for improving the quality of life and reducing the impact of this debilitating disease. Given that the global distribution of COPD continues to rise exponentially, addressing respiratory health priorities has become crucial for improving the quality of life and reducing the impact of this debilitating disease. IMPROVING CARE FOR PEOPLE WITH CHRONIC RESPIRATORY DISEASES This report was initiated and funded by AstraZeneca, who commissioned The Health Policy Partnership to develop it with insights from an expert steering committee. All members of the steering committee have had the opportunity to review the report, and AstraZeneca reviewed the report for factual accuracy. None of the experts involved ... Introduction People living with advanced respiratory diseases do not receive the supportive and palliative care that they need to have the best possible qualityof life [1 – 4]. Globally, many millions of people live with advanced respiratory diseases [5], including chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Given that the global distribution of COPD continues to rise exponentially, addressing respiratoryhealth priorities has become crucial for improving the qualityof life and reducing the impact of this debilitating disease. May 7, 2025 · Goals of medical management of individuals with chronic obstructive pulmonary disease (COPD) should be to live better and live longer—in other words, improve health-related qualityof life (HRQL) and survival. This narrative review summarizes the literature in these areas, with an emphasis on pulmonary rehabilitation (PR). Treatments that increase HRQL include pharmacologic agents, exercise ...
Advances In Hormonal Balance Through Medication
Advances In Neurological Disorders Based On Clinical Studies
Treating Neurological Disorders And Long-Term Care
